Clinical Trial

Anti-obesity Pharmacotherapy and Inflammation

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 9, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the relationship between weight loss, circulating inflammatory markers and lipids from 24 patients before and after 6 months of pharmacotherapy as a standard of care for anti-obesity treatment
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2023-03-03; most recent amendment 2025-09-02.
Status change: Recruiting → Active, Not Recruiting 2025-01-08
Status change: Not Yet Recruiting → Recruiting 2023-10-02
Trial Details
NCT Number NCT05756764
Lead Sponsor Louisiana State University Health Sciences Center in New Orleans
Collaborators: Tulane University, Pennington Biomedical Research Center, Ochsner Health System
Conditions Obesity
Enrollment 30 participants
Start Date 2023-06-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-02-20 (estimated)
Updated on ClinicalTrials.gov 2025-09-09